eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   o   Check drugs   o   Compare drugs   o   Report a side effect
Join a support group   o   Ask a question   o   Write a review   o   Answered/ Unanswered   o   Reviews

Review: could Tysabri cause Progressive multifocal leukoencephalopathy?

Summary: Progressive multifocal leukoencephalopathy is found among people who take Tysabri, especially for people who are female, 40-49 old, have been taking the drug for 2 - 5 years, also take medication Baclofen, and have Multiple sclerosis.

We study 97,547 people who have side effects while taking Tysabri from FDA and social media. Among them, 2,943 have Progressive multifocal leukoencephalopathy. Find out below who they are, when they have Progressive multifocal leukoencephalopathy and more.

You are not alone: join a support group for people who take Tysabri and have Progressive multifocal leukoencephalopathy >>>

 

Tysabri

Tysabri has active ingredients of natalizumab. It is often used in multiple sclerosis. (latest outcomes from 97,688 Tysabri users)

Progressive multifocal leukoencephalopathy

Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells) has been reported by people with multiple sclerosis, relapsing-remitting multiple sclerosis, chronic lymphocytic leukaemia, non-hodgkin's lymphoma, rheumatoid arthritis. (latest reports from 5,167 Progressive multifocal leukoencephalopathy patients)

On Mar, 27, 2015: 97,547 people reported to have side effects when taking Tysabri. Among them, 2,943 people (3.02%) have Progressive Multifocal Leukoencephalopathy.

Trend of Progressive multifocal leukoencephalopathy in Tysabri reports

Time on Tysabri when people have Progressive multifocal leukoencephalopathy * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years
Progressive multifocal leukoencephalopathy2.76%3.48%4.88%15.32%68.96%4.56%0.04%

Gender of people who have Progressive multifocal leukoencephalopathy when taking Tysabri * :

FemaleMale
Progressive multifocal leukoencephalopathy68.23%31.77%

Age of people who have Progressive multifocal leukoencephalopathy when taking Tysabri * :

0-12-910-1920-2930-3940-4950-5960+
Progressive multifocal leukoencephalopathy0.00%0.00%0.74%6.41%23.34%37.93%21.97%9.62%

Severity of Progressive multifocal leukoencephalopathy when taking Tysabri ** :

leastmoderateseveremost severe
Progressive multifocal leukoencephalopathy0.00%0.00%0.00%100.00%

How people recovered from Progressive multifocal leukoencephalopathy ** :

n/a

Top conditions involved for these people * :

  1. Multiple sclerosis (2,186 people, 74.28%)
  2. Relapsing-remitting multiple sclerosis (638 people, 21.68%)
  3. Depression (180 people, 6.12%)
  4. Muscle spasticity (146 people, 4.96%)
  5. Fatigue (99 people, 3.36%)

Top co-used drugs for these people * :

  1. Baclofen (213 people, 7.24%)
  2. Vitamin d (146 people, 4.96%)
  3. Lyrica (108 people, 3.67%)
  4. Provigil (103 people, 3.50%)
  5. Zanaflex (100 people, 3.40%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Get connected: join our support group of tysabri and progressive multifocal leukoencephalopathy on

Do you have Progressive Multifocal Leukoencephalopathy while taking Tysabri?

 

 

 

You are not alone! Join a mobile support group on :
- support group for people who take Tysabri and have Progressive Multifocal Leukoencephalopathy
- support group for people who take Tysabri
- support group for people who have Progressive Multifocal Leukoencephalopathy

Drugs in real world that are associated with:

Could your condition cause:

Recent related drug studies (Check your drugs):

Recent Tysabri related drug comparison:

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.